Effects of Vaccinations With HLA-A2-Restricted Glioma Antigen-Peptides in Combination With Poly-ICLC for Adults With High-Risk WHO Grade II Astrocytomas and Oligo-Astrocytomas
This study is ongoing, but not recruiting participants.
Ian F. Pollack, M.D.
Information provided by (Responsible Party):
Ian F. Pollack, M.D., University of Pittsburgh
First received: November 19, 2008
Last updated: September 10, 2014
Last verified: September 2014
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is ongoing, but not recruiting participants.|
|Estimated Study Completion Date:||September 2015|
|Primary Completion Date:||February 2013 (Final data collection date for primary outcome measure)|